Photo by nci from unsplash
Key Points • OGM achieves diagnostic outcomes equivalent to, and in 13% of cases better than, standard-of-care technologies in a real-world setting.• OGM may uncover findings that would alter recommended… Click to show full abstract
Key Points • OGM achieves diagnostic outcomes equivalent to, and in 13% of cases better than, standard-of-care technologies in a real-world setting.• OGM may uncover findings that would alter recommended clinical care or render cases eligible for clinical trials.
Keywords:
myeloid leukemia;
genome mapping;
optical genome;
acute myeloid;
leukemia multicenter;
mapping acute
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!